5-HT6 receptor blockade differentially affects scopolamine-induced deficits of working memory, recognition memory and aversive learning in mice

Psychopharmacology

Volumn 222, Issue 1, 2012, Pages 99-115

  Da Silva Costa Aze, Virginie ^a,b   Quiedeville, Anne ^a   Boulouard, Michel ^a   Dauphin, François ^a  

^a UNIVERSITÉ DE CAEN   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Aversive learning; Mouse; Passive avoidance; Place recognition; Recognition memory; SB 271046; Scopolamine; Spontaneous alternation; Working memory

Indexed keywords

5 CHLORO N [4 METHOXY 3 (1 PIPERAZINYL)PHENYL] 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; SCOPOLAMINE;

AGING; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVERSIVE BEHAVIOR; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOSE RESPONSE; DRUG EFFICACY; EPISODIC MEMORY; FEMALE; LEARNING; MAZE TEST; MEMORY DISORDER; MOUSE; NEUROTRANSMISSION; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RECOGNITION; TREATMENT OUTCOME; WORKING MEMORY;

ANIMALS; AVOIDANCE LEARNING; CHOLINERGIC ANTAGONISTS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MEMORY DISORDERS; MEMORY, SHORT-TERM; MICE; RECEPTORS, SEROTONIN; SCOPOLAMINE HYDROBROMIDE; SEROTONIN ANTAGONISTS; SULFONAMIDES; THIOPHENES;

EID: 84861855874     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2627-3     Document Type: Article

References (62)

1. Bazin MA, El Kihel L, Boulouard M, Bouet V, Rault S (2009) The effects of DHEA, 3beta-hydroxy-5alpha-androstane-6,17-dione, and 7-amino-DHEA analogues on short termand long term memory in the mouse. Steroids 74:931-937
2. Boissier JR, Simon P (1965) Action of caffeine on the spontaneous motility of the mouse. Arch Int Pharmacodyn Ther 158:212-221
3. Bontempi B,Whelan KT, Risbrough VB, Lloyd GK,Menzaghi F (2003) Cognitive enhancing properties and tolerability of cholinergic agents inmice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors. Neuropsychopharmacology 28:1235-1246 (Pubitemid 41070893)
4. Cassel JC, Jeltsch H (1995) Serotonergic modulation of cholinergic function in the central nervous system: cognitive implications. Neuroscience 69:1-41
5. Costall B, Jones BJ, Kelly ME, Naylor RJ, Tomkins DM (1989) Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol Biochem Behav 32:777-785 (Pubitemid 19162403)
6. Da Silva Costa V, Duchatelle P, Boulouard M, Dauphin F (2009) Selective 5-HT6 receptor blockade improves spatial recognition memory and reverses age-related deficits in spatial recognition memory in the mouse. Neuropsychopharmacology 34:488-500
7. Da Silva Costa-Aze V, Dauphin F, Boulouard M (2011) Selective 5-HT6 receptor blockade reverses the age-related deficits of recognition memory and working memory in mice. Behav Brain Res 222:134-140
8. Dawson LA, Nguyen HQ, Li P (2000) In vivo effects of the 5-HT(6) antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate. Br J Pharmacol 130:23-26 (Pubitemid 30248421)
9. Dawson LA, Nguyen HQ, Li P (2001) The 5-HT(6) receptor antagonist SB-271046 selec- tively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacology 25:662-668 (Pubitemid 32995948)
10. de Bruin NMWJ, Prickaerts J, van Loevezijn A, Venhorst J, de Groote L, Houba P, Reneerkens O, Akkerman S, Kruse CG (2011) Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats. Neurobiol Learn Mem 96:392-402
11. Decker MW, McGaugh JL (1991) The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory. Synapse 7:151-168
12. Deiana S, Harrington CR, Wischik CM, Riedel G (2009) Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine. Psychopharmacology (Berl) 202:53-65
13. Dellu F, Mayo W, Cherkaoui J, Le Moal M, Simon H (1992) A two-trial memory task with automated recording: study in young and aged rats. Brain Res 588:132-139
14. Dellu F, Contarino A, Simon H, Koob GF, Gold LH (2000) Genetic differences in response to novelty and spatial memory using a twotrial recognition task in mice. Neurobiol Learn Mem 73:31-48 (Pubitemid 30167117)
15. Dember WN, Fowler H (1958) Spontaneous alternation behavior. Psychol Bull 55:412-428
16. Dudchenko PA (2004) An overview of the tasks used to test working memory in rodents. Neurosci Biobehav Rev 28:699-709
17. Eriksson TM, Madjid N, Elvander-Tottie E, Stiedl O, Svenningsson P, Ogren SO (2008) Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and glutamatergic neurotransmission. Neuropharmacology 54:1041-1050
18. Fleischman DA, Gabrieli J (1999) Long-term memory in Alzheimer's disease. Curr Opin Neurobiol 9:240-244 (Pubitemid 29201799)
19. Foley AG, Murphy KJ, Hirst WD, Gallagher HC, Hagan JJ, Upton N, Walsh FS, Regan CM (2004) The 5-HT(6) receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats. Neuropsychopharmacology 29:93-100 (Pubitemid 38068018)
20. Gravius A, Lasly J, Pietraszek M, Saghy K, Nagel J, Chambon C, Wegener N, Valastro B, Danysz W, Gyertyan I (2011) Effects of 5-HT6 antagonists, Ro-4368554 and SB-258585, in tests used the detection of cognitive enhancement and antipsychotic-like activity. Behav Pharmacol 22:122-135
21. Hamon M, Doucet E, Lefevre K, Miquel MC, Lanfumey L, Insausti R, Frechilla D, Del Rio J, Verge D (1999) Antibodies and antisense oligonucleotide for probing the distribution and putative functions of central 5-HT6 receptors. Neuropsychopharmacology 21:68S-76S
22. Hasselmo ME, SarterM(2011) Modes and models of forebrain cholinergic neuromodulation of cognition. Neuropsychopharmacology 36:52-73
23. Hirst WD, Abrahamsen B, Blaney FE, Calver AR, Aloj L, Price GW, Medhurst AD (2003) Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling. Mol Pharmacol 64:1295-1308 (Pubitemid 37532219)
24. HirstWD, Stean TO, Rogers DC, Sunter D, Pugh P, Moss SF, Bromidge SM, Riley G, Smith DR, Bartlett S, Heidbreder CA, Atkins AR, Lacroix LP, Dawson LA, Foley AG, Regan CM, Upton N (2006) SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models. Eur J Pharmacol 553:109-119 (Pubitemid 44779592)
25. Jarvik ME, Kopp R (1967) An improved one-trial passive avoidance learning situation. Psychol Rep 21:221-224
26. King MV, Sleight AJ, Woolley ML, Topham IA, Marsden CA, Fone KC (2004) 5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation-an effect sensitive to NMDA receptor antagonism. Neuro-pharmacology 47:195-204 (Pubitemid 38824643)
27. KingMV,Marsden CA, Fone KC (2008) A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning andmemory. Trends Pharmacol Sci 29:482-492
28. Klinkenberg I, Blokland A (2010) The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci Biobehav Rev 34:1307-1350
29. Klinkenberg I, Blokland A (2011) A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment. Psychopharmacology (Berl) 215:549-566
30. Lelong V, Lhonneur L, Dauphin F, Boulouard M (2003) BIMU 1 and RS 67333, two 5-HT4 receptor agonists, modulate spontaneous alternation deficits induced by scopolamine in the mouse. Naunyn Schmiedebergs Arch Pharmacol 367:621-628 (Pubitemid 36829461)
31. Lelong-Boulouard V, Quentin T, Moreaux F, Debruyne D, Boulouard M, Coquerel A (2006) Interactions of buprenorphine and dipotassium clorazepate on anxiety and memory functions in the mouse. Drug Alcohol Depend 85:103-113 (Pubitemid 44468139)
32. Lieben CK, Blokland A, Sik A, Sung E, van Nieuwenhuizen P, Schreiber R (2005) The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the rat. Neuropsychopharmacology 30:2169-2179 (Pubitemid 41643968)
33. Lindeboom J, Weinstein H (2004) Neuropsychology of cognitive ageing, minimal cognitive impairment, Alzheimer's disease, and vascular cognitive impairment. Eur J Pharmacol 490:83-86 (Pubitemid 38482162)
34. Marcos B, Gil-Bea FJ, Hirst WD, Garcia-Alloza M, Ramirez MJ (2006) Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release. Eur J Neurosci 24:1299-1306 (Pubitemid 44401652)
35. Marcos B, Chuang TT, Gil-Bea FJ, Ramirez MJ (2008) Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat. Br J Pharmacol 155:434-440
36. Marcy R, Quermonne MA (1975) Benzodiazepines: a comparison of their effects in mice on the magnitude of the palmar skin conductivity response and on pentylenetetrazole-induced seizures. Experientia 31:954-955
37. Marcy R, Quermonne MA, Nammathao B (1976) Habituation to iterative photostimulation in the palmar skin conductance response of mice, its delay by psychoanaleptics. Experientia 32:208-209
38. Mitchell ES, Hoplight BJ, Lear SP, Neumaier JF (2006) BGC20-761, a novel tryptamine analog, enhances memory consolidation and reverses scopolamine-induced memory deficit in social and visuo-spatial memory tasks through a 5-HT6 receptor-mediated mechanism. Neuropharmacology 50:412-420 (Pubitemid 43209037)
39. Otano A, Frechilla D, Cobreros A, Cruz-Orive LM, Insausti A, Insausti R, HamonM, Del Rio J (1999) Anxiogenic-like effects and reduced stereological counting of immunolabelled 5-hydroxytryptamine6 receptors in rat nucleus accumbens by antisense oligonucleotides. Neuroscience 92:1001-1009 (Pubitemid 29287545)
40. Perez-Garcia G, Meneses A (2005) Oral administration of the 5-HT6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task. Pharmacol Biochem Behav 81:673-682 (Pubitemid 40966815)
41. Pitsikas N, Zisopoulou S, Pappas I, Sakellaridis N (2008) The selective 5-HT(6) receptor antagonist Ro 04-6790 attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801. Behav Brain Res 188:304-309
42. Richman CL, Dember WN, Kim P (1986) Spontaneous alternation behavior in animals: a review. Curr Psychol Res Rev 5:358-391
43. Riemer C, Borroni E, Levet-Trafit B, Martin JR, Poli S, Porter RH, Bos M (2003) Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4- sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist. J Med Chem 46:1273-1276 (Pubitemid 36428233)
44. Rogers DC, Hagan JJ (2001) 5-HT6 receptor antagonists enhance retention of a water maze task in the rat. Psychopharmacology (Berl) 158:114-119 (Pubitemid 33020829)
45. Rush DK (1988) Scopolamine amnesia of passive avoidance: a deficit of information acquisition. Behav Neural Biol 50:255-274
46. Schliebs R, Arendt T (2006) The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transm 113:1625-1644 (Pubitemid 44657659)
47. Schreiber R, Vivian J, Hedley L, Szczepanski K, Secchi RL, Zuzow M, van Laarhoven S, Moreau JL, Martin JR, Sik A, Blokland A (2007) Effects of the novel 5-HT(6) receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating. Eur Neuropsychopharmacology 17:277-288 (Pubitemid 46135932)
48. Shirazi-Southall S, Rodriguez DE, Nomikos GG (2002) Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Neuropsychopharmacology 26:583-594 (Pubitemid 34260977)
49. Sridhar N, Veeranjaneyulu A, Arulmozhi DK, Gupta CN, Babu RJ (2002) 5-HT3 receptors in selective animal models of cognition. Indian J Exp Biol 40(2):174-180 (Pubitemid 34147280)
50. Steckler T, Sahgal A (1995) The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour. Behav Brain Res 67:165-199
51. Steckler T, Drinkenburg WH, Sahgal A, Aggleton JP (1998) Recognition memory in rats-II. Neuroanatomical substrates. Prog Neurobiol 54:313-332 (Pubitemid 28112649)
52. Svenningsson P, Tzavara ET, Qi H, Carruthers R, Witkin JM, Nomikos GG, Greengard P (2007) Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation. J Neurosci 27:4201-4209 (Pubitemid 46597167)
53. Tassone A, Madeo G, Schirinzi T, Vita D, Puglisi F, Ponterio G, Borsini F, Pisani A, Bonsi P (2011) Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission. Neuropharmacology. doi:10.1016/j.neuropharm.2011.05.004
54. Torquet N, Hagues J, Costentin J (2008) The reduction in electric footshocks perception interferes with the amnesic effect of scopolamine. Behav Brain Res 188:238-240
55. Tulving E (2001) Episodic memory and common sense: how far apart? Philos Trans R Soc Lond B Biol Sci 356:1505-1515
56. Wesolowska A (2008) The anxiolytic-like effect of the selective 5-HT6 receptor antagonist SB-399885: the impact of benzodiazepine receptors. Eur J Pharmacol 580:355-360
57. Wesolowska A (2010) Potential role of the 5-HT6 receptor in depression and anxiety; an overview of preclinical data. Pharmacol Rep 62:564-577
58. Wesolowska A, Nikiforuk A (2007) Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression. Neuropharmacology 52:1274-1283 (Pubitemid 46527703)
59. Wesolowska A, Nikiforuk A, Stachowicz K (2007) Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats. Behav Pharmacol 18:439-446 (Pubitemid 47356370)
60. Woolley ML, Bentley JC, Sleight AJ, Marsden CA, Fone KC (2001) A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze. Neuropharmacology 41:210-219 (Pubitemid 32728092)
61. Woolley ML, Marsden CA, Sleight AJ, Fone KC (2003) Reversal of a cholinergic-induced deficit in a rodentmodel of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790. Psycho-pharmacology (Berl) 170:358-367 (Pubitemid 38010507)
62. Zhang MY, Hughes ZA, Kerns EH, Lin Q, Beyer CE (2007) Development of a liquid chromatography/tandem mass spectrometrymethod for the quantitation of acetylcholine and related neurotransmitters in brain microdialysis samples. J Pharm Biomed Anal 44:586-593 (Pubitemid 46880097)